Asgard Therapeutics announces appointment of three members Axel Schambach, MD PhD, Johanna Olweus, MD PhD, and Joshua Brody, MD to its Newly Formed Scientific Advisory Board (SAB).
Read moreAsgard Therapeutics was featured at the Nature Biopharma dealmakers new collection, highlighting companies developing innovative cell and gene therapies. Take a closer look at how Asgard’s in-vivo direct reprogramming approach can convert tumor cells into antigen-presenting dendritic cells and turn cold tumors hot.
Read moreFrom a collective of 40 selected start-ups, Asgard Therapeutics was awarded the runner-up prize as part of the NLSDays Investment Track.
Read moreLund, Sweden, 13 September 2022 – Asgard Therapeutics AB (“Asgard”), a private biotech company pioneering...
Read moreLund, Sweden – 01 June – Asgard Therapeutics AB (“Asgard”) today announces that the United States...
Read moreAsgard Therapeutics announces today that the Eurostars-funded project REPRogramming tumors INTo immune cells - a revolutionary gene therapy to treat cancer (REPRINT) - has officially kicked-off.
Read moreThe world wealthiest look for cellular reprogramming as the key for longevity with limitless funds for research
Read more“A growing interest in the field and even a fear of missing out on a revolutionary approach.”
Read moreCheck out the newest feature in @bpdealmakers that selected @AsgardThx platform technology as an innovative gene therapy to reprogram anti-cancer immunity. #Immunotherapy #biopharma https://www.nature.com/articles/d43747-022-00220-4
Check out the newest feature in @bpdealmakers that selected @AsgardThx platform technology as an innovative gene therapy to reprogram anti-cancer immunity. #Immunotherapy #biopharma https://www.nature.com/articles/d43747-022-00220-4
We are excited to be part of the #NLSdays and network in this vibrant environment.
Feel free to reach out to @_CristianaPires and Fabio Rosa to know more about our mission in #cancerimmunotherapy.
#asgardthx #startup #innovation
Join @AsgardThx welcoming Martin Bonde as our new Chair of the Board of Directors.
Welcome to team Martin! http://bit.ly/3DpQReq
7-year journey = 7 words in my new title:
Professor in #molecular #medicine, #regeneration, #transplantation and #repair in the #hematopoietic #system.
Full Professor at @medfak_LU @lunduniversity, what’s next?
@Lund_Stem @LuWcmm
Congrats to @AsgardThx and Filipe Pereira (@CellReproLab), winners of the 2020 ISMMS-KiiLN award, on their seed round and growing team! @MtSinaiPostdocs @MountSinaiAlum @IcahnMountSinai @ISMMSPostdocOff @MountSinai_IP #SINAInnovations http://shorturl.at/otJT5
Cristiana Pires CEO of Asgard is proud to participate in the US Camp promoted by the @MentorNordic (NOME) taking place in San Francisco, USA. Thank you @CALifeSciences for organizing the programme!
#collaboration #Asgard
https://nome.nu/
#ISSCR2022 has started! Exciting science coming!
Filipe Pereira Co-Founder and Head of Innovation at Asgard will be presenting at the @ISSCR in San Francisco, USA, on the 16th of June at 17:15-19:00 (GMT-7). Don’t miss this opportunity!
#TrojanDC #Immunotherapy
https://www.isscr.org/meetings-events/annual-meetings/isscr-annual-meeting-2022
The Asgard team today took part in helping to raise awareness for the @CancerResearch (CRI), Immunotherapy Month, as we wish to bring further awareness to this topic this month from all our members!
#immune2cancer #trojanDC
;